Loading clinical trials...
Loading clinical trials...
Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder (ASD)
Conditions
Interventions
Neuropeptide Y
Placebo
Locations
2
United States
New York Medical College
Valhalla, New York, United States
Westchester Medical Center
Valhalla, New York, United States
Start Date
November 1, 2019
Primary Completion Date
October 31, 2022
Completion Date
November 1, 2022
Last Updated
August 28, 2019
NCT05674617
NCT06000475
NCT03887559
NCT06088303
NCT06296589
NCT04501328
Lead Sponsor
New York Medical College
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions